Skip to main content
Top
Published in:

Open Access 01-12-2024 | Research

Periodontitis and dental quality of life predict long-term survival in head and neck cancer

Authors: Mirna Farran, Evelyn Neppelberg, Sigbjørn Løes, Anne K. H. Aarstad, Svein Erik Moe, Hans Jørgen Aarstad

Published in: BMC Oral Health | Issue 1/2024

Login to get access

Abstract

Background

Our aim was to investigate oral health in newly diagnosed head and neck squamous cell carcinoma (HNSCC) patients in relation to long-term survival. We assessed whether the level of alveolar bone loss due to periodontitis at diagnosis, measured from orthopantomogram (OPG), and reported dental health-related quality of life (HRQoL) scores obtained at diagnosis contain prognostic information for HNSCC patients.

Methods

A total of 79 patients from a consecutive cohort of 106 diagnosed with HNSCC between November 2002 and June 2005 were included. All patients reported dental HRQoL, OPG-determined alveolar bone loss were measured in 79 patients at diagnosis. Reduced alveolar bone loss (≥ 4 mm) from cement-enamel junction on at least two molars or premolars registered both horizontally and vertically served as indicator of periodontal disease.

Results

With alveolar bone loss, we determined increased mortality by univariate analysis (RR = 2.28, CI: 1.22–4.28, p = 0.01) and a strong trend by multivariate analyses adjusted for standard clinical information (RR = 1.95, CI: 0.98–3.87, p = 0.056). Reported lowered dental HRQoL scores predicted long-term survival in both univariate (RR = 3.58, CI: 1.99–6.45, p < 0.001) and multivariate adjusted for standard clinical information (RR = 2.17, CI: 1.17–4.01, p = 0.014). When analyzed with Cox regression, including alveolar bone loss and dental HRQoL, both factors, adjusted by clinical variables, were significant predictors of long-term survival: dental HRQoL (p = 0.007) and present alveolar bone loss (p = 0.034). Non-HNSCC disease-specific long-term survival predicted was also predicted when alveolar bone loss and dental HRQoL were analyzed simultaneously and adjusted for standard clinical information.

Conclusions

The degree of alveolar bone loss, as determined by OPG, and dental HRQoL both obtained at the time of HNSCC diagnosis, predicted long-term survival. When analyzed simultaneously, both factors remained significant in both univariate and multivariate analyses, adjusted by pertinent clinical variables, highlighting their unique prognostic value.
Literature
1.
go back to reference Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.CrossRefPubMed Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.CrossRefPubMed
2.
go back to reference Cunha ARD, Compton K, Xu R, Mishra R, Drangsholt MT, Antunes JLF, Kerr AR, Acheson AR, Lu D, Wallace LE, et al. The Global, Regional, and National Burden of Adult Lip, oral, and pharyngeal Cancer in 204 countries and territories: a systematic analysis for the global burden of Disease Study 2019. JAMA Oncol. 2023;9(10):1401–16.CrossRefPubMedPubMedCentral Cunha ARD, Compton K, Xu R, Mishra R, Drangsholt MT, Antunes JLF, Kerr AR, Acheson AR, Lu D, Wallace LE, et al. The Global, Regional, and National Burden of Adult Lip, oral, and pharyngeal Cancer in 204 countries and territories: a systematic analysis for the global burden of Disease Study 2019. JAMA Oncol. 2023;9(10):1401–16.CrossRefPubMedPubMedCentral
3.
go back to reference Cancer Registry of Norway. Cancer in Norway 2021- Cancer incidence, mortality, survival and prevalance in Norway. In. Oslo: Cancer Registry of Norway: Oslo: Cancer Registry of Norway; 2022. Cancer Registry of Norway. Cancer in Norway 2021- Cancer incidence, mortality, survival and prevalance in Norway. In. Oslo: Cancer Registry of Norway: Oslo: Cancer Registry of Norway; 2022.
4.
go back to reference Varoni EM, Lodi G, Iriti M. Ethanol versus phytochemicals in wine: oral Cancer risk in a light drinking perspective. Int J Mol Sci. 2015;16(8):17029–47.CrossRefPubMedPubMedCentral Varoni EM, Lodi G, Iriti M. Ethanol versus phytochemicals in wine: oral Cancer risk in a light drinking perspective. Int J Mol Sci. 2015;16(8):17029–47.CrossRefPubMedPubMedCentral
5.
go back to reference Zumsteg ZS, Luu M, Rosenberg PS, Elrod JK, Bray F, Vaccarella S, Gay C, Lu DJ, Chen MM, Chaturvedi AK, Goodman MT. Global epidemiologic patterns of oropharyngeal cancer incidence trends. J Natl Cancer Inst. 2023;115(12):1544–54.CrossRefPubMedPubMedCentral Zumsteg ZS, Luu M, Rosenberg PS, Elrod JK, Bray F, Vaccarella S, Gay C, Lu DJ, Chen MM, Chaturvedi AK, Goodman MT. Global epidemiologic patterns of oropharyngeal cancer incidence trends. J Natl Cancer Inst. 2023;115(12):1544–54.CrossRefPubMedPubMedCentral
6.
go back to reference Moe SE, Erland FA, Fromreide S, Lybak S, Brydoy M, Dongre HN, Dhayalan SM, Costea DE, Vintermyr OK, Aarstad HJ. The TP53 Codon 72 Arginine Polymorphism Is Found with Increased TP53 Somatic Mutations in HPV(-) and in an Increased Percentage among HPV(+) Norwegian HNSCC Patients. Biomedicines. 2023;11(7). Moe SE, Erland FA, Fromreide S, Lybak S, Brydoy M, Dongre HN, Dhayalan SM, Costea DE, Vintermyr OK, Aarstad HJ. The TP53 Codon 72 Arginine Polymorphism Is Found with Increased TP53 Somatic Mutations in HPV(-) and in an Increased Percentage among HPV(+) Norwegian HNSCC Patients. Biomedicines. 2023;11(7).
7.
go back to reference Ljokjel B, Lybak S, Haave H, Olofsson J, Vintermyr OK, Aarstad HJ. The impact of HPV infection on survival in a geographically defined cohort of oropharynx squamous cell carcinoma (OPSCC) patients in whom surgical treatment has been one main treatment. Acta Otolaryngol. 2014;134(6):636–45.CrossRefPubMed Ljokjel B, Lybak S, Haave H, Olofsson J, Vintermyr OK, Aarstad HJ. The impact of HPV infection on survival in a geographically defined cohort of oropharynx squamous cell carcinoma (OPSCC) patients in whom surgical treatment has been one main treatment. Acta Otolaryngol. 2014;134(6):636–45.CrossRefPubMed
8.
go back to reference Yu J, Qin W, Huang W, Thomas K. Oral health and mortality among older adults: a doubly robust survival analysis. Am J Prev Med. 2023;64(1):9–16.CrossRefPubMed Yu J, Qin W, Huang W, Thomas K. Oral health and mortality among older adults: a doubly robust survival analysis. Am J Prev Med. 2023;64(1):9–16.CrossRefPubMed
10.
go back to reference Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol. 2021;21(7):426–40.CrossRefPubMedPubMedCentral Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol. 2021;21(7):426–40.CrossRefPubMedPubMedCentral
12.
go back to reference Zhang J, Bellocco R, Sandborgh-Englund G, Yu J, Sällberg Chen M, Ye W. Poor oral health and esophageal Cancer risk: a Nationwide Cohort Study. Cancer Epidemiol Biomarkers Prev. 2022;31(7):1418–25.CrossRefPubMed Zhang J, Bellocco R, Sandborgh-Englund G, Yu J, Sällberg Chen M, Ye W. Poor oral health and esophageal Cancer risk: a Nationwide Cohort Study. Cancer Epidemiol Biomarkers Prev. 2022;31(7):1418–25.CrossRefPubMed
13.
go back to reference Wong T, Wiesenfeld D. Oral Cancer. Aust Dent J. 2018;63(Suppl 1):S91–9.PubMed Wong T, Wiesenfeld D. Oral Cancer. Aust Dent J. 2018;63(Suppl 1):S91–9.PubMed
15.
go back to reference Arimoto N, Nishimura R, Kobayashi T, Asaeda M, Naito T, Kojima M, Umemura O, Yokota M, Hanada N, Kawamura T, et al. Effects of oral health-related quality of life on total mortality: a prospective cohort study. BMC Oral Health. 2023;23(1):708.CrossRefPubMedPubMedCentral Arimoto N, Nishimura R, Kobayashi T, Asaeda M, Naito T, Kojima M, Umemura O, Yokota M, Hanada N, Kawamura T, et al. Effects of oral health-related quality of life on total mortality: a prospective cohort study. BMC Oral Health. 2023;23(1):708.CrossRefPubMedPubMedCentral
16.
go back to reference Osthus AA, Aarstad AK, Olofsson J, Aarstad HJ. Prediction of survival by pretreatment health-related quality-of-life scores in a prospective cohort of patients with head and neck squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2013;139(1):14–20.CrossRefPubMed Osthus AA, Aarstad AK, Olofsson J, Aarstad HJ. Prediction of survival by pretreatment health-related quality-of-life scores in a prospective cohort of patients with head and neck squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2013;139(1):14–20.CrossRefPubMed
17.
go back to reference Douglas C, Hewitt L, Yabe TE, Mitchell J, Ashford B. Quality of life impacts following surgery for Advanced Head and Neck Cancer. World J Oncol. 2023;14(2):150–7.CrossRefPubMedPubMedCentral Douglas C, Hewitt L, Yabe TE, Mitchell J, Ashford B. Quality of life impacts following surgery for Advanced Head and Neck Cancer. World J Oncol. 2023;14(2):150–7.CrossRefPubMedPubMedCentral
18.
go back to reference Martínez Ú, Brandon KO, Sutton SK, Brandon TH, Simmons VN. Does smoking abstinence predict cancer patients’ quality of life over time? Psychooncology. 2019;28(8):1702–11.CrossRefPubMedPubMedCentral Martínez Ú, Brandon KO, Sutton SK, Brandon TH, Simmons VN. Does smoking abstinence predict cancer patients’ quality of life over time? Psychooncology. 2019;28(8):1702–11.CrossRefPubMedPubMedCentral
19.
go back to reference Chattopadhyay I, Verma M, Panda M. Role of oral Microbiome signatures in diagnosis and prognosis of oral Cancer. Technol Cancer Res Treat. 2019;18:1533033819867354.CrossRefPubMedPubMedCentral Chattopadhyay I, Verma M, Panda M. Role of oral Microbiome signatures in diagnosis and prognosis of oral Cancer. Technol Cancer Res Treat. 2019;18:1533033819867354.CrossRefPubMedPubMedCentral
20.
go back to reference King R, Li C, Lowe D, Rogers SN. An audit of dental assessments including orthopantomography and timing of dental extractions before radiotherapy for head and neck cancer. Br Dent J. 2022;232(1):38–43.CrossRefPubMed King R, Li C, Lowe D, Rogers SN. An audit of dental assessments including orthopantomography and timing of dental extractions before radiotherapy for head and neck cancer. Br Dent J. 2022;232(1):38–43.CrossRefPubMed
21.
go back to reference Farran M, Løes SS, Vintermyr OK, Lybak S, Aarstad HJ. Periodontal status at diagnosis predicts non-disease-specific survival in a geographically defined cohort of patients with oropharynx squamous cell carcinoma. Acta Otolaryngol. 2019;139(3):309–15.CrossRefPubMed Farran M, Løes SS, Vintermyr OK, Lybak S, Aarstad HJ. Periodontal status at diagnosis predicts non-disease-specific survival in a geographically defined cohort of patients with oropharynx squamous cell carcinoma. Acta Otolaryngol. 2019;139(3):309–15.CrossRefPubMed
22.
go back to reference Holmstrup P, Damgaard C, Olsen I, Klinge B, Flyvbjerg A, Nielsen CH, Hansen PR. Comorbidity of periodontal disease: two sides of the same coin? An introduction for the clinician. J Oral Microbiol. 2017;9(1):1332710.CrossRefPubMedPubMedCentral Holmstrup P, Damgaard C, Olsen I, Klinge B, Flyvbjerg A, Nielsen CH, Hansen PR. Comorbidity of periodontal disease: two sides of the same coin? An introduction for the clinician. J Oral Microbiol. 2017;9(1):1332710.CrossRefPubMedPubMedCentral
23.
go back to reference Bueno AC, Ferreira RC, Cota LO, Silva GC, Magalhaes CS, Moreira AN. Comparison of different criteria for periodontitis case definition in head and neck cancer individuals. Support Care Cancer. 2015;23(9):2599–604.CrossRefPubMed Bueno AC, Ferreira RC, Cota LO, Silva GC, Magalhaes CS, Moreira AN. Comparison of different criteria for periodontitis case definition in head and neck cancer individuals. Support Care Cancer. 2015;23(9):2599–604.CrossRefPubMed
24.
go back to reference Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP. The Eighth Edition AJCC Cancer staging Manual: continuing to build a bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–9.CrossRefPubMed Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP. The Eighth Edition AJCC Cancer staging Manual: continuing to build a bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–9.CrossRefPubMed
25.
go back to reference Aarstad HJ, Osthus AA, Aarstad HH, Lybak S, Aarstad AKH. General health-related quality of life scores from head and neck squamous cell carcinoma patients obtained throughout the first year following diagnosis predicted up to 10-year overall survival. Eur Arch Otorhinolaryngol. 2018;275(1):207–17.CrossRefPubMed Aarstad HJ, Osthus AA, Aarstad HH, Lybak S, Aarstad AKH. General health-related quality of life scores from head and neck squamous cell carcinoma patients obtained throughout the first year following diagnosis predicted up to 10-year overall survival. Eur Arch Otorhinolaryngol. 2018;275(1):207–17.CrossRefPubMed
26.
go back to reference Lybak S, Ljokjel B, Haave H, Karlsdottir A, Vintermyr OK, Aarstad HJ. Primary surgery results in no survival benefit compared to primary radiation for oropharyngeal cancer patients stratified by high-risk human papilloma virus status. Eur Arch Otorhinolaryngol. 2017;274(1):477–87.CrossRefPubMed Lybak S, Ljokjel B, Haave H, Karlsdottir A, Vintermyr OK, Aarstad HJ. Primary surgery results in no survival benefit compared to primary radiation for oropharyngeal cancer patients stratified by high-risk human papilloma virus status. Eur Arch Otorhinolaryngol. 2017;274(1):477–87.CrossRefPubMed
27.
go back to reference Noel CW, Stephens RF, Su JS, Xu W, Krahn M, Monteiro E, Goldstein DP, Giuliani M, Hansen AR, de Almeida JR. Mapping the EORTC QLQ-C30 and QLQ-H&N35, onto EQ-5D-5L and HUI-3 indices in patients with head and neck cancer. Head Neck. 2020;42(9):2277–86.CrossRefPubMed Noel CW, Stephens RF, Su JS, Xu W, Krahn M, Monteiro E, Goldstein DP, Giuliani M, Hansen AR, de Almeida JR. Mapping the EORTC QLQ-C30 and QLQ-H&N35, onto EQ-5D-5L and HUI-3 indices in patients with head and neck cancer. Head Neck. 2020;42(9):2277–86.CrossRefPubMed
28.
go back to reference Monteiro AR, Garcia AR, Pereira TC, Macedo F, Soares RF, Pereira K, Serra T, Khouri L, Ribeiro J, Teixeira MM. ACE-27 as a prognostic tool of severe acute toxicities in patients with head and neck cancer treated with chemoradiotherapy: a real-world, prospective, observational study. Support Care Cancer. 2021;29(4):1863–71.CrossRefPubMed Monteiro AR, Garcia AR, Pereira TC, Macedo F, Soares RF, Pereira K, Serra T, Khouri L, Ribeiro J, Teixeira MM. ACE-27 as a prognostic tool of severe acute toxicities in patients with head and neck cancer treated with chemoradiotherapy: a real-world, prospective, observational study. Support Care Cancer. 2021;29(4):1863–71.CrossRefPubMed
29.
go back to reference Qian Y, Cai B, Chi F, Yao C, Zhang L, Qi L, Jiang Y, Wang X. Alveolar bone loss and tooth loss contribute to increase in cancer mortality among older patients. BMC Oral Health. 2023;23(1):1023.CrossRefPubMedPubMedCentral Qian Y, Cai B, Chi F, Yao C, Zhang L, Qi L, Jiang Y, Wang X. Alveolar bone loss and tooth loss contribute to increase in cancer mortality among older patients. BMC Oral Health. 2023;23(1):1023.CrossRefPubMedPubMedCentral
30.
go back to reference Qian Y, Yu H, Yuan W, Wu J, Xu Q, Mei N, Wang X, Wang C. Alveolar bone loss, tooth loss and oral Cancer mortality in older patients: a retrospective cohort study. Clin Interv Aging. 2020;15:1419–25.CrossRefPubMedPubMedCentral Qian Y, Yu H, Yuan W, Wu J, Xu Q, Mei N, Wang X, Wang C. Alveolar bone loss, tooth loss and oral Cancer mortality in older patients: a retrospective cohort study. Clin Interv Aging. 2020;15:1419–25.CrossRefPubMedPubMedCentral
31.
go back to reference Osthus AA, Aarstad AK, Olofsson J, Aarstad HJ. Head and neck specific health related Quality of Life scores predict subsequent survival in successfully treated head and neck cancer patients: a prospective cohort study. Oral Oncol. 2011;47(10):974–9.CrossRefPubMed Osthus AA, Aarstad AK, Olofsson J, Aarstad HJ. Head and neck specific health related Quality of Life scores predict subsequent survival in successfully treated head and neck cancer patients: a prospective cohort study. Oral Oncol. 2011;47(10):974–9.CrossRefPubMed
32.
go back to reference Mody MD, Rocco JW, Yom SS, Haddad RI, Saba NF. Head and neck cancer. Lancet. 2021;398(10318):2289–99.CrossRefPubMed Mody MD, Rocco JW, Yom SS, Haddad RI, Saba NF. Head and neck cancer. Lancet. 2021;398(10318):2289–99.CrossRefPubMed
33.
go back to reference Nazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci (Qassim). 2017;11(2):72–80.PubMed Nazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci (Qassim). 2017;11(2):72–80.PubMed
34.
go back to reference Hach M, Holm-Pedersen P, Adegboye AR, Avlund K. The effect of alcohol consumption on periodontitis in older danes. Int J Dent Hyg. 2015;13(4):261–7.CrossRefPubMed Hach M, Holm-Pedersen P, Adegboye AR, Avlund K. The effect of alcohol consumption on periodontitis in older danes. Int J Dent Hyg. 2015;13(4):261–7.CrossRefPubMed
35.
go back to reference Caton JG, Armitage G, Berglundh T, Chapple ILC, Jepsen S, Kornman KS, Mealey BL, Papapanou PN, Sanz M, Tonetti MS. A new classification scheme for periodontal and peri-implant diseases and conditions - introduction and key changes from the 1999 classification. J Periodontol. 2018;89(Suppl 1):S1–8.PubMed Caton JG, Armitage G, Berglundh T, Chapple ILC, Jepsen S, Kornman KS, Mealey BL, Papapanou PN, Sanz M, Tonetti MS. A new classification scheme for periodontal and peri-implant diseases and conditions - introduction and key changes from the 1999 classification. J Periodontol. 2018;89(Suppl 1):S1–8.PubMed
36.
go back to reference Meyle J, Chapple I. Molecular aspects of the pathogenesis of periodontitis. Periodontol 2000. 2015;69(1):7–17.CrossRefPubMed Meyle J, Chapple I. Molecular aspects of the pathogenesis of periodontitis. Periodontol 2000. 2015;69(1):7–17.CrossRefPubMed
37.
go back to reference Kavarthapu A, Gurumoorthy K. Linking chronic periodontitis and oral cancer: a review. Oral Oncol. 2021;121:105375.CrossRefPubMed Kavarthapu A, Gurumoorthy K. Linking chronic periodontitis and oral cancer: a review. Oral Oncol. 2021;121:105375.CrossRefPubMed
38.
go back to reference Akbari E, Epstein JB, Samim F. Unveiling the hidden links: Periodontal Disease, Fusobacterium Nucleatum, and cancers. Curr Oncol Rep. 2024. Akbari E, Epstein JB, Samim F. Unveiling the hidden links: Periodontal Disease, Fusobacterium Nucleatum, and cancers. Curr Oncol Rep. 2024.
39.
go back to reference Pignatelli P, Nuccio F, Piattelli A, Curia MC. The role of Fusobacterium nucleatum in oral and colorectal carcinogenesis. Microorganisms. 2023;11(9). Pignatelli P, Nuccio F, Piattelli A, Curia MC. The role of Fusobacterium nucleatum in oral and colorectal carcinogenesis. Microorganisms. 2023;11(9).
41.
go back to reference Aarstad HH, Moe SEE, Bruserud Ø, Lybak S, Aarstad HJ, Tvedt THA. The Acute Phase Reaction and Its Prognostic Impact in Patients with Head and Neck Squamous Cell Carcinoma: Single Biomarkers Including C-Reactive Protein Versus Biomarker Profiles. Biomedicines. 2020;8(10). Aarstad HH, Moe SEE, Bruserud Ø, Lybak S, Aarstad HJ, Tvedt THA. The Acute Phase Reaction and Its Prognostic Impact in Patients with Head and Neck Squamous Cell Carcinoma: Single Biomarkers Including C-Reactive Protein Versus Biomarker Profiles. Biomedicines. 2020;8(10).
42.
go back to reference Engebretson S, Gelato M, Hyman L, Michalowicz BS, Schoenfeld E. Design features of the diabetes and Periodontal Therapy Trial (DPTT): a multicenter randomized single-masked clinical trial testing the effect of nonsurgical periodontal therapy on glycosylated hemoglobin (HbA1c) levels in subjects with type 2 diabetes and chronic periodontitis. Contemp Clin Trials. 2013;36(2):515–26.CrossRefPubMed Engebretson S, Gelato M, Hyman L, Michalowicz BS, Schoenfeld E. Design features of the diabetes and Periodontal Therapy Trial (DPTT): a multicenter randomized single-masked clinical trial testing the effect of nonsurgical periodontal therapy on glycosylated hemoglobin (HbA1c) levels in subjects with type 2 diabetes and chronic periodontitis. Contemp Clin Trials. 2013;36(2):515–26.CrossRefPubMed
Metadata
Title
Periodontitis and dental quality of life predict long-term survival in head and neck cancer
Authors
Mirna Farran
Evelyn Neppelberg
Sigbjørn Løes
Anne K. H. Aarstad
Svein Erik Moe
Hans Jørgen Aarstad
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Oral Health / Issue 1/2024
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-024-05170-0